PSYCHEMEDICS CORPORATION: 10-Q filed 2016-10-27
What PSYCHEMEDICS CORPORATION reported in its quarterly report filed 2016-10-27 (fiscal Q3 2016): 32 published measures, 89 facts as tagged in accession 0001144204-16-129813.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-10-27
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001144204-16-129813 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PSYCHEMEDICS CORPORATION filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 25,928,555 | USD | |
| At 2015-12-31 | 22,362,968 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 12,025,738 | USD | |
| At 2015-12-31 | 10,689,438 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 13,902,817 | USD | |
| At 2015-12-31 | 11,673,530 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,111,808 | USD | |
| At 2015-12-31 | 2,689,464 | USD | |
| At 2015-09-30 | 1,721,894 | USD | |
| At 2014-12-31 | 3,612,153 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 2,708,021 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 4,318,332 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 796,385 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,326,237 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 1,181,244 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 1,091,683 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -6,486,010 | USD | |
| At 2015-12-31 | -8,296,738 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 5,459,802 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 5,441,967 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 5,422,541 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 5,399,131 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 5,510,042 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 5,457,368 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 5,424,989 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 5,406,053 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 0.5 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | 0.79 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0.15 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.25 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 0.49 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | 0.79 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0.15 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.25 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,362,111 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,051,053 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -275,612 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -63,106 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 12,926,146 | USD | |
| At 2015-12-31 | 13,132,114 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 507,888 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 514,422 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 4,104,036 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 6,473,422 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 551,184 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,357,745 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 12,186,422 | USD | |
| At 2015-12-31 | 8,456,380 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 5,497,524 | USD | |
| At 2015-12-31 | 3,564,556 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,144,236 | USD | |
| At 2015-12-31 | 747,291 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 6,272,108 | USD | |
| At 2015-12-31 | 3,538,765 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 3,000,854 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 8,579,055 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 2,905,499 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 8,707,548 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 7,104,890 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 15,052,477 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 3,456,683 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 10,065,293 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 347,970 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,058,633 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 392,042 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,284,914 | USD | 273 |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 5,226,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 8,240,883 | USD | |
| At 2015-12-31 | 6,642,501 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 815,987 | USD | |
| At 2015-12-31 | 774,474 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,587,584 | USD | |
| At 2015-12-31 | 1,197,632 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,266,409 | USD | |
| At 2015-12-31 | 1,060,587 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 4,070,132 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 6,369,385 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 520,773 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,263,131 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,277,988 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,715,838 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,229,441 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 3,528,020 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 1,625,979 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 1,102,112 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 2,733,343 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 1,375,031 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 321,524 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -209,627 | USD | 273 |
Inspect the source
- Entity
- PSYCHEMEDICS CORPORATION / CIK 0000806517
- Captured
- 2026-09-21T17:17:03.097Z
- SEC response SHA-256
86f20b52a099e76620fe6881a053ed61515c47925a0b1b6a4ed64f7b833f6a17
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000806517.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))